Adamax is not an incremental Semax update. It is a structurally enhanced heptapeptide analogue — an N-amantadyl-glutaryl modified MEHFPGP variant with dramatically extended plasma half-life, superior BBB penetration and exponentially stronger BDNF/NGF neurogenesis response. Peak cognitive research instrumentation without catecholamine spike.
The biochemical premise — an advanced heptapeptide architecture with amantadyl anchor
In the peptide research field, Semax (MEHFPGP) was long considered the gold standard for neurotrophic research modulation. Adamax breaks that ceiling. Through N-terminal conjugation with an amantadyl-glutaryl group, the molecule acquires a dramatically enhanced lipophilic profile, resulting in superior blood-brain barrier penetration and significantly extended central half-life.
The difference is not incremental — it is exponential. Where Semax displays its acute BDNF response within 30-60 minutes and clears within hours, Adamax maintains in pre-clinical models a sustained neurotrophic upregulation for 12-24 hours. The result: maximal neurogenesis stimulation without repeated exposure, with enhanced dendritic sprouting and long-term synaptic plasticity.
Adamax (N-Amantadyl-Glu-Met-Glu-His-Phe-Pro-Gly-Pro-OH, MW: ~1.012 kDa) retains the canonical ACTH 4-7 + Pro-Gly-Pro backbone of Semax, but the lipophilic amantadyl anchor confers a fundamentally different pharmacokinetic profile.
"Semax fires the neuron. Adamax builds the dendrite."
In this respect, Adamax is fundamentally distinct from classical "cognitive enhancement research peptides" — it is not merely a stronger dose of Semax, it is a structurally different research instrument with its own pharmacodynamic signature.
What does Adamax do razor-sharp differently?
Adamax operates on multiple layers simultaneously, with enhanced amplitude and extended duration versus conventional heptapeptide analogues:
- NGF expression significantly upregulated → measurable dendritic sprouting and synaptic density increase in chronic models
- Dopamine D2/D3 extended activation without catecholamine release → focus response over hours instead of minutes
- Adult neurogenesis in subgranular zone (dentate gyrus) significantly elevated → measurable BrdU+/DCX+ cells
- Synaptic plasticity (LTP) enhanced in hippocampal slice preparations → late-LTP phase prolonged
- Neuroprotective response in ischemic research models with superior infarct reduction versus Semax control
- Amantadyl anchor confers NMDA modulation → mild antagonistic profile on excitotoxic cascades
Adamax vs Semax — Side-by-Side
| Property | Adamax (Super-Enhanced) | Semax (Classic ACTH 4-7) |
|---|---|---|
| Backbone | N-Amantadyl-Glu-MEHFPGP | Met-Glu-His-Phe-Pro-Gly-Pro |
| Molecular mass | ~1.012 kDa | 813.94 g/mol |
| N-terminal modification | Amantadyl-glutaryl anchor | Free N-terminus |
| Lipophilic profile | Strongly elevated | Moderate |
| BBB penetration | Superior | Good |
| Central half-life | 12-24 hours | 30-90 min (acute) |
| BDNF acute response | Strong | Strong |
| BDNF sustained | Very strong over 24h | Limited (acute profile) |
| NGF chronic | Very strong · measurable dendritic sprouting | Strong |
| Adult neurogenesis (BrdU+/DCX+) | Significantly elevated in dentate gyrus | Limited |
| Dopamine D2/D3 | Extended activation (hours) | Acute activation (minutes) |
| NMDA modulation via amantadyl | Mild antagonistic | Absent |
| Synaptic LTP late-phase | Enhanced | Enhanced |
| Ischemic neuroprotection | Superior infarct reduction profile | Strong |
| HPLC purity Primal lot | ≥99% | ≥99% |
| Optimal research role | Peak neurogenesis · long-term cognitive research | Acute focus research |
The biochemical conclusion: Semax is the acute neurotrophic trigger — it rapidly elevates BDNF and dopamine D2/D3 for focus and attention. Adamax is the structural neurogenesis architect — it builds the dendritic arborization, supports long-term synaptic plasticity and activates adult neurogenesis in the dentate gyrus. Both are complementary: Semax for acute tasks, Adamax for chronic research protocols. In comparative in-vitro models, Adamax+Semax is often positioned as the complete cognitive research suite — acute trigger + structural build-up.
The Molecular Mechanics
At the level of central nervous system cultures and in-vivo behavioral models, the following effects of Adamax are documented:
- NGF chronically very strongly upregulated → measurable dendritic sprouting and synaptic density increase in chronic research models
- TrkA and TrkB receptor signaling extended activation → prolonged CREB phosphorylation window
- Late-LTP phase enhanced in hippocampal slice preparations → long-term memory consolidation
- Synapsin-I and PSD-95 expression elevated → enhanced pre- and post-synaptic architecture
- No tachyphylaxis in chronic in-vitro models with chronic exposure — unique for extended-action neurotrophic peptide research
For research into adult neurogenesis and dendritic sprouting, Adamax delivers a unique profile — a research domain where acute heptapeptides do not reach:
- BrdU+/DCX+ cell counts in subgranular zone (SGZ) of the dentate gyrus significantly elevated in chronic animal models
- Dendritic arborization complexity (Sholl analysis) enhanced in hippocampal neurons
- Spine density on apical dendrites elevated in pyramidal neurons of CA1
- Neurite outgrowth in cortex cultures enhanced versus Semax control in matched dose-response studies
- Doublecortin (DCX) expression as marker for immature neurons elevated
- Synergistic action with physical-stimulation research models (environmental enrichment paradigm)
The most unique Adamax property is combined neurotrophic response and mild NMDA antagonism via the amantadyl anchor — a dual-pathway mechanism:
- Mild NMDA receptor antagonism via the amantadyl component → protection against excitotoxic damage in ischemic research models
- Glutamate-mediated excitotoxicity attenuated in cortex cultures under oxygen-glucose deprivation (OGD)
- Superior infarct zone reduction in middle cerebral artery occlusion (MCAO) rat models versus Semax control
- Anti-apoptotic response enhanced (elevated Bcl-2/Bax ratio, reduced caspase-3 activation)
- Microglia activation significantly attenuated in chronic neuroinflammation models (TNF-α, IL-6, IL-1β reduced)
- Mitochondrial membrane potential protected during metabolic stress in cortex cultures
The Primal Peptides standard
Every batch is independently validated. The Certificate of Analysis (COA) is the binding source of truth for each lot — publicly available, batch-specific and generated by an independent third-party laboratory prior to shipment. We publish no claims that are not per lot supported by the COA.
- 01RP-HPLC with UV detection → purity ≥ 98–99%
- 02Mass spectrometry → molecular mass confirmation
- 03Janoshik 3rd-party verification → public COA per lot
Our validation architecture is deliberately minimalist and strict: three reproducible assays, one independent verification, one public certificate. For the complete analytical dossier of your specific batch, consult the COA with your shipment or via our public verification page.
Adamax combines neurotrophic upregulation with mild NMDA modulation and has a dramatically extended central half-life. Research protocols must strictly control attention baselines, dopamine D2/D3 sensitivity, glutamate baselines and any co-administration with other NMDA-active research compounds (memantine references, ketamine models) in animal models. Legal disclaimer: Adamax is intended exclusively for IN-VITRO RESEARCH. Not for human use. Not for consumption. Not for nasal or oral self-administration.
Conclusion — The architect of maximal neurogenesis
Adamax is not another enhanced Semax. It is a dedicated structurally enhanced heptapeptide analogue that sustainedly activates BDNF, NGF, adult neurogenesis and synaptic plasticity via an amantadyl-glutaryl architecture — with dual-pathway mechanism combining neurotrophic response and mild NMDA modulation. For researchers who wish to study peak neurogenesis, dendritic sprouting and long-term cognitive plasticity in a molecularly targeted manner, Adamax is the missing super-heptapeptide instrument.
Architecture over activation. Sprouting over spiking. Building over briefing.
Adamax
Πρότυπο αναφοράς απευθείας από το εργαστήριο Primal Peptides EU – vacuum-sealed, ανώνυμο και διακριτικά αποσταλμένο εντός της ΕΕ. Αυστηρά πρωτόκολλα αποθήκευσης στους −20 °C πριν την αποστολή εγγυώνται την ακεραιότητα της παρτίδας.
ΜΟΝΟ ΓΙΑ IN-VITRO ΕΡΕΥΝΑ · ΟΧΙ ΓΙΑ ΑΝΘΡΩΠΙΝΗ ΧΡΗΣΗ · ΣΥΝΘΕΣΗ ΣΥΜΦΩΝΗ ΜΕ GMP